News | January 12, 2011

SCAI Publishes Commentary on Future Cath Labs

January 12, 2011 – The Society for Cardiovascular Angiography and Interventions (SCAI) has published a paper on the future trends and developments in the cardiac catheterization laboratory and interventional vascular suite. The paper, titled "The Catheterization Laboratory and Interventional Vascular Suite of the Future: Anticipating Innovations in Design and Function," appears in the current issue of Catheterization and Cardiovascular Interventions.

It features predictions on the future of these medical spaces, including advances in technology and design as well as changes in function, staffing and economics. Specifically, it says that improvements and innovations will be stimulated by patients’ needs.

Advancements in medical technology accompanied by improved patient outcomes have led to an increase in the number of catheter-based therapies performed by clinicians. This trend is expected to continue with the discovery of novel techniques and superior medical technology. As science continues to guide medical advancement, the design and functionality of the cath lab and interventional vascular suite will likely continue to evolve. To achieve this, the paper recommends working with teams of physicians, scientists, regulators and manufacturers to create a functional suite for patients and staff.

"The future of the catheterization lab and interventional vascular suite is exciting to think about as we seek to continue improving patient care through minimally invasive techniques," said Lloyd Klein, M.D., FSCAI, professor of medicine at Rush Medical College and lead author of the paper. "As new therapies are pioneered we have the opportunity to collaborate and provide patients with state-of-the art facilities that ensure the highest quality of service and care, while offering a functional and safe medical environment for both patients and staff."

Medical advancements have also shifted trends in cardiac care, including a new case mix with fewer diagnostic catheterizations, earlier diagnosis of blocked arteries and increased use of combined (or hybrid) procedures. The number of structural heart disease patients treated with catheter-based treatments is likely to increase, as will patients treated for valvular disease.

According the paper, the future cath labs will likely include design and technology features such as:
• Robotic catheter manipulation directed by advanced imaging systems

• Miniaturization of therapeutic devices

• Integration of visual and other data from multiple sources, including the availability of archival solutions that are easily available and transferable to other medical professionals for consultation

• Advanced digital imaging, detailed 3-dimensional reconstruction and molecular imaging

• Utilization of virtual interfaces, trial procedures using virtual reality, and intelligent navigation during a procedure

• A dedicated information technology staff to manage ever-changing hardware, applications and monitoring programs that improve efficiency, eliminate disparate information and improve patient satisfaction

The paper also forecasts the future functionality of the cath lab, predicting two different interventional laboratory types. The first will be reminiscent of today's cath lab but will include greater diagnostic capability and improved patient comfort through decoration, lighting and diversions. The second will be a much larger alternative surgical suite equipped with large and complex imaging modalities and used for more complex procedures. This suite would be staffed and equipped to accommodate open surgery procedures, something not common in today's labs. Additionally, the lab design will minimize patient and staff radiation dose, allow for database consolidation and pooled learning, incorporate a sophisticated storage and inventory management system, and improve catheter navigation and device placement.

For more information: www.scai.org/asset.axd?id=5339d216-2efe-4a71-bee6-d602815eac4a&t=634302607018830000

Related Content

New Alliance Announced Between Transcatheter Cardiovascular Therapeutics and VEITHsymposium
News | Cath Lab | June 20, 2019
VEITHsymposium and the Cardiovascular Research Foundation (CRF) announced an alliance between Transcatheter...
Novel Index Accurately Predicts PCI Success Post-Procedure Compared to Established Measurement Metrics
News | Cath Lab | June 19, 2019
Results from a comprehensive analysis demonstrate the effectiveness of measuring a non-hyperemic pressure ratio (NHPR...
Philips Healthcare, Volcano IVUS showing an implanted stent. IVUS might offer an alternative to contrast angiography in patients with acute kidney disease (AKD).
News | Cath Lab | June 14, 2019
June 14, 2019 – A late-breaking study examined the effects of intravascular ultrasound (IVUS) guided drug-eluting ste
Videos | Cath Lab | May 20, 2019
This is a walk through of the primary structural heart hybrid cath lab at...
Mobility May Predict Elderly Heart Attack Survivors' Repeat Hospital Stays
News | Cath Lab | April 23, 2019
Determining which elderly heart attack patients take longer to stand from a seated position and walk across a room may...
FDA Releases New Guidance on Medical Devices Containing Nitinol
News | Cath Lab | April 18, 2019
April 18, 2019 — The U.S.
Angiography shows a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL lithoplasty.

Figure 2: Angiography demonstrates a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification (double-headed arrow) in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL (inset; note the cavitation bubbles generated by IVL [black arrows]). (D) OCT cross-sectional (top) and longitudinal (bottom) images acquired post-IVL and coregistered to the OCT lens (white arrow in C) demonstrate multiple calcium fractures and large acute luminal gain. (E) Angiography demonstrates complete stent expansion with the semicompliant stent balloon (inset) without the need for high-pressure noncompliant balloon inflation. (F) OCT cross-sectional (top) and longitudinal (bottom) images acquired post-stenting and coregistered to the OCT lens (arrow in E) demonstrate further fracture displacement (arrow), with additional increase in the acute area gain (5.17 mm2), resulting in full stent expansion and minimal malapposition.

Feature | Cath Lab | April 15, 2019 | Dean Kereiakes, M.D., FACC, FSCAI, and Jonathan Hill, M.D., DISRUPT CAD III Co-Principal Investigators
Over the last 40 years, despite multiple advancements in percutaneous coronary interventions, calcified lesions remai
BIOTRONIK’s PK Papyrus covered coronary stent. The stent ius used in emergency coronary artery dissections to repair the vessel wall.
Technology | Cath Lab | April 15, 2019
April 15, 2019 — Biotronik began its U.S.
Overlay Init